Partner Courtenay Brinckerhoff contributed an article to
Life Sciences Intellectual Property Review, “
Will You, Won’t You, Will You Join the Dance?” on July 30, 2015. In the article, Brinckerhoff discusses the implications and unanswered questions for the biosimilars framework after the U.S. Court of Appeals for the Federal Circuit ruled in Amgen v. Sandoz that biosimilar applicants can opt out of the “patent dance.”